Resolutions adopted by the Extraordinary Shareholder Meeting of Syn2bio SA on 19 May 2026
19.05.2026
See also
Synektik shareholders have unanimously approved the division of the company and spinoff of the cardiotracer project to Syn2bio
- Corporate news
- Investor relations
Synektik plans to devide. It is spinning off the cardiotracer research project into a new company which will also be listed on the WSE
- Corporate news
- Investor relations
Synektik one step closer to planned division
- Corporate news
- Investor relations